These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 25358476

  • 1. Coronary collateral circulation in patients with chronic coronary total occlusion; its relationship with cardiac risk markers and SYNTAX score.
    Börekçi A, Gür M, Şeker T, Baykan AO, Özaltun B, Karakoyun S, Karakurt A, Türkoğlu C, Makça I, Çaylı M.
    Perfusion; 2015 Sep; 30(6):457-64. PubMed ID: 25358476
    [Abstract] [Full Text] [Related]

  • 2. Epicardial fat thickness in stable coronary artery disease: its relationship with high-sensitive cardiac troponin T and N-terminal pro-brain natriuretic peptide.
    Börekçi A, Gür M, Özaltun B, Baykan AO, Harbalioğlu H, Seker T, Sen Ö, Acele A, Gözükara MY, Kuloğlu O, Koç M, Çayli M.
    Coron Artery Dis; 2014 Dec; 25(8):685-90. PubMed ID: 25004239
    [Abstract] [Full Text] [Related]

  • 3. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C, Prontera C, Liga R, De Graaf MA, Gaemperli O, Lorenzoni V, Ragusa R, Marinelli M, Del Ry S, Rovai D, Giannessi D, Aguade-Bruix S, Clemente A, Bax JJ, Lombardi M, Sicari R, Zamorano J, Scholte AJ, Kaufmann PA, Knuuti J, Underwood SR, Clerico A, Neglia D.
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [Abstract] [Full Text] [Related]

  • 4. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
    Avouac J, Meune C, Chenevier-Gobeaux C, Dieudé P, Borderie D, Lefevre G, Kahan A, Allanore Y.
    J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
    [Abstract] [Full Text] [Related]

  • 5. Unstable coronary plaque characteristics are associated with high-sensitivity cardiac troponin T and N-terminal Pro-Brain Natriuretic Peptide.
    Altintas S, Cardinaels EP, Versteylen MO, Joosen IA, Seifert M, Wildberger JE, Crijns HJ, Nelemans PJ, Van Dieijen-Visser MP, Mingels AM, Das M, Kietselaer BL.
    J Cardiovasc Comput Tomogr; 2016 Feb; 10(1):82-8. PubMed ID: 26481512
    [Abstract] [Full Text] [Related]

  • 6. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [Abstract] [Full Text] [Related]

  • 7. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
    Lyngbæk S, Winkel P, Gøtze JP, Kastrup J, Gluud C, Kolmos HJ, Kjøller E, Jensen GB, Hansen JF, Hildebrandt P, Hilden J, CLARICOR Trial Group.
    Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
    [Abstract] [Full Text] [Related]

  • 8. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
    Voroneanu L, Siriopol D, Nistor I, Apetrii M, Hogas S, Onofriescu M, Covic A.
    Kidney Blood Press Res; 2014 Oct; 39(6):636-47. PubMed ID: 25571877
    [Abstract] [Full Text] [Related]

  • 9. The association of plasma vitamin A and E levels with coronary collateral circulation.
    Söğüt E, Kadı H, Karayakalı M, Mertoğlu C.
    Atherosclerosis; 2015 Apr; 239(2):547-51. PubMed ID: 25728388
    [Abstract] [Full Text] [Related]

  • 10. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
    Avouac J, Meune C, Chenevier-Gobeaux C, Borderie D, Lefevre G, Kahan A, Allanore Y.
    Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1022-30. PubMed ID: 25604469
    [Abstract] [Full Text] [Related]

  • 11. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH, Arpegård J, Ostergren J, Svensson P.
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [Abstract] [Full Text] [Related]

  • 12. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A.
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [Abstract] [Full Text] [Related]

  • 13. [The relationship between coronary collateral circulation and blood high-sensitivity C-reactive protein levels].
    Kadı H, Ceyhan K, Karayakalı M, Koç F, Celik A, Onalan O.
    Turk Kardiyol Dern Ars; 2011 Jan; 39(1):23-8. PubMed ID: 21358227
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY, Lam CW, Wang M, Chan IH, Lui SF, Zhang Y, Sanderson JE.
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [Abstract] [Full Text] [Related]

  • 15. Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population.
    Xu R, Ye P, Luo L, Sheng L, Wu H, Xiao W, Zheng J, Wang F, Xiao T.
    Chin Med J (Engl); 2014 Jun; 127(4):638-44. PubMed ID: 24534215
    [Abstract] [Full Text] [Related]

  • 16. Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study.
    Feistritzer HJ, Reinstadler SJ, Klug G, Reindl M, Wöhrer S, Brenner C, Mayr A, Mair J, Metzler B.
    BMC Cardiovasc Disord; 2016 Nov 28; 16(1):239. PubMed ID: 27894261
    [Abstract] [Full Text] [Related]

  • 17. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
    Cameron SJ, Sokoll LJ, Laterza OF, Shah S, Green GB.
    Clin Chim Acta; 2007 Feb 28; 376(1-2):168-73. PubMed ID: 17011538
    [Abstract] [Full Text] [Related]

  • 18. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
    Harutyunyan MJ, Mathiasen AB, Winkel P, Gøtze JP, Hansen JF, Hildebrandt P, Jensen GB, Hilden J, Jespersen CM, Kjøller E, Kolmos HJ, Gluud C, Kastrup J, CLARICOR Trial Group.
    Scand J Clin Lab Invest; 2011 Feb 28; 71(1):52-62. PubMed ID: 21108561
    [Abstract] [Full Text] [Related]

  • 19. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
    Peer A, Falkensammer G, Alber H, Kroiss A, Griesmacher A, Ulmer H, Pachinger O, Mair J.
    Heart; 2009 Feb 28; 95(4):297-303. PubMed ID: 18708421
    [Abstract] [Full Text] [Related]

  • 20. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S, Dimko M, Galani A, Coppola B, Innico G, Frassetti N, Mazzei ED, Mariotti A.
    Ren Fail; 2015 Mar 28; 37(2):254-61. PubMed ID: 25394527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.